Borenius advised joint global coordinators and joint bookrunners on DNA’s EUR 474 million initial public offering
We advised Danske Bank and Morgan Stanley as joint global coordinators, and J.P. Morgan, Nordea, and SEB as joint bookrunners, on the initial public offering and Nasdaq Helsinki listing of DNA Oyj. Trading on DNA’s shares began on 2 December 2016 on the official list of Nasdaq Helsinki and it was the largest genuine IPO in Finland in a decade.
The offering comprised a secondary sale by DNA’s two largest shareholders, Finda Oy and PHP Holding Oy, among other selling shareholders, and a primary issuance by DNA for total gross proceeds of EUR 474.3 million (including the over-allotment option) giving DNA a market capitalization at listing of approximately EUR 1.34 billion.
DNA is one of the leading telecommunications service providers in Finland with its own nationwide mobile and fixed network.